Merck & Co Inc

NYSE:MRKHealthcareCBOE:SPESGDJ:DJA

$143.63−1.59%At closeAt close · Tue 20 Oct · ≈ AED 527.48 · Market cap $354.36B · Next earnings Thu 29 Oct · Extended $144.50 +0.61%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	67.2%	72.0%	70.6%	73.2%	76.3%	72.0%	—	—
Operating margin	13.4%	27.1%	30.8%	4.9%	31.5%	36.2%	36.2%	+0.0 pts
Net margin	17.0%	26.8%	24.5%	0.6%	26.7%	28.1%	28.1%	+0.0 pts
EBITDA margin	24.5%	36.8%	36.0%	11.5%	40.1%	43.5%	—	—
Return on equity	27.9%	34.2%	31.6%	1.0%	37.0%	34.7%	34.7%	−0.0 pts
Return on assets	7.7%	12.3%	13.3%	0.3%	14.6%	13.3%	13.3%	+0.0 pts
Return on capital employed	8.6%	16.1%	21.5%	3.6%	22.8%	21.6%	—	—
Debt / equity	1.3×	0.9×	0.7×	1.0×	0.8×	1.0×	1.0×	−0.1%
Debt / assets	36.5%	32.8%	29.3%	34.0%	32.7%	36.9%	—	—
Interest coverage	6.7×	16.4×	19.0×	2.6×	15.9×	17.3×	—	—
Current ratio	1.0×	1.3×	1.5×	1.3×	1.4×	1.5×	1.5×	+0.0%
Quick ratio	0.8×	1.0×	1.2×	1.0×	1.1×	1.3×	—	—
Cash ratio	0.3×	0.3×	0.5×	0.3×	0.5×	0.5×	0.5×	+0.0%
Asset turnover	0.5×	0.5×	0.5×	0.6×	0.5×	0.5×	—	—
Inventory turnover	2.5×	2.3×	2.9×	2.5×	2.5×	2.7×	—	—
Receivables turnover	6.1×	5.3×	6.3×	5.8×	6.2×	5.1×	—	—
Dividend payout	87.9%	50.7%	48.3%	2,039.7%	45.8%	44.8%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.